A collaborative study published in Immunity from the Batista Lab and Liu Lab at the Ragon Institute, together with the Schief Lab at Scripps Research Institute, has uncovered a previously unrecognized ...
FDA approval of the B-cell depleting monoclonal antibody inebilizumab-cdon (Uplizna) a year ago for immunoglobulin (Ig)G4-related disease (RD) has cemented B-cell depletion as current first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results